The Patent Finder

Medivation Technologies, Inc.

Also on record
Records under this name other than the patents Medivation Technologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 19 patents it holds.

Back to Medivation Technologies, Inc.

PatentTitleStatus Expires Confidence
US 8,541,403Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency
Lapsed on the fee record
Ended Sep 24, 2025 · From the USPTO record
Lapsed on the fee recordEnded Sep 24, 2025From the USPTO record
US 10,493,078Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency
Lapsed on the fee record
Ended Dec 3, 2023 · From the USPTO record
Lapsed on the fee recordEnded Dec 3, 2023From the USPTO record
US 9,018,201Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency
Lapsed on the fee record
Ended Apr 28, 2023 · From the USPTO record
Lapsed on the fee recordEnded Apr 28, 2023From the USPTO record
US 10,189,826Heterocyclic compounds and methods of use
Lapsed on the fee record
Ended Jan 29, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jan 29, 2023From the USPTO record
US 10,183,015Heterocyclic compounds and methods of use
Lapsed on the fee record
Ended Jan 22, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jan 22, 2023From the USPTO record
US 9,670,172Heterocyclic compounds and methods of use
Lapsed on the fee record
Ended Jun 6, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jun 6, 2021From the USPTO record
US 9,580,425Pyrido[3,4-b] indoles and methods of use
Lapsed on the fee record
Ended Feb 28, 2021 · From the USPTO record
Lapsed on the fee recordEnded Feb 28, 2021From the USPTO record
US 9,527,854Compounds and methods for treatment of hypertension
Lapsed on the fee record
Ended Dec 27, 2020 · From the USPTO record
Lapsed on the fee recordEnded Dec 27, 2020From the USPTO record
US 8,338,408Tetracyclic compounds
Lapsed on the fee record
Ended Dec 25, 2020 · From the USPTO record
Lapsed on the fee recordEnded Dec 25, 2020From the USPTO record
US 8,338,447Pyrido[3,4-B]indoles and methods of use
Lapsed on the fee record
Ended Dec 25, 2020 · From the USPTO record
Lapsed on the fee recordEnded Dec 25, 2020From the USPTO record
10 of 51 patents shown.
Pro members see all 51.
Pro members: see all 51 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited